United States set
language
Menu Shopping cart $0 Search

References to miR-222-3p

  • Amini S, Abak A, Estiar MA, Montazeri V, Abhari A, Sakhinia E" Expression Analysis of MicroRNA-222 in Breast Cancer." Clin Lab. 64(4):491-496 (2018).
  • Garofalo M, Quintavalle C, Romano G, Croce CM, and Condorelli G. "miR221/222 in Cancer: Their Role in Tumor Progression and Response to Therapy." Curr Mol Med; 12(1): 27–33 (2012).
  • Galardi S, Mercatelli N, Giorda E, et al. "miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27kip1. " J Biol Chem; 282(32):23716–23724 (2007).
  • Le Sage C, Nagel R, Egan DA, et al. "Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. " EMBO J.; 26:3699–3708 (2007).
  • Visone R, Russo L, Pallante P, et al. "MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. " Endocr Relat Cancer; 14(3):791–798 (2007).
  • Miller TE, Ghoshal K, Ramaswamy B, et al. "MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1." J Biol Chem.; 283(44):29897–29903 (2008).
  • Fu X, Wang Q, Chen J, et al. "Clinical significance of miR-221 and its inverse correlation with p27Kip1 in hepatocellular carcinoma. " Mol Biol Rep.; 38(5):3029–3035 (2011).
  • Garofalo M, Quintavalle C, Di Leva G, et al. "MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer. Oncogene. " 27(27):3845–3855 (2008).
  • Yi-An Chang, et al. "A Three–MicroRNA Signature as a Potential Biomarker for the Early Detection of Oral Cancer." Int. J. Mol. Sci., 19, 758 (2018).
  • Jianping guo, et al. "mir-222-3p promotes osteosarcoma cell migration and invasion through targeting TiMP3." OncoTargets and Therapy ,11:8643–8653 (2018).
  • TylerE.Miller et al. "MicroRNA-221/222 Confers Tamoxifen Resistance in Breast CancerbyTargetingp27Kip1." Journal of biological chemistry, 283:44 (2008).